|
|
|
Sunday, March 25, 2007 - 1:30 PM, Manchester D - F
|
- Selected Topics in Bone Pathology
|
|
Moderator:
|
Sharon Weiss, Emory University Hospital, Atlanta, GA
|
|
|
Disclosure:
|
In accordance with ACCME guidelines regarding disclosure, the USCAP policy requires that faculty members who have a significant financial or other relationship with a commercial company, entity, or service (which will be discussed in this Symposium) must disclose this to attendees. The Academy also requires that speakers disclose any products that are not labeled for the use under discussion. Dr. A. Kevin Raymond indicated he is a consultant for Eli Lilly Pharmaceuticals and has financial interest in Novartis Pharmaceuticals (lectures). All other faculty members for this Symposium have indicated they have no disclosures to make.
|
Click the button above to add this event to your Itinerary Planner...
 Click here to download handout in 1-per-page format for the meeting
Click here to download handout in 6-per-page format for the meeting
Click any blue title below to display and print the handout for individual lecture(s):
| 1:30 | The Five Things You Need to Know About Bone Before Signing Your Report - Michael Klein, University of Alabama Medical Center, Birmingham, AL |
| 2:15 | Chondrosarcoma and Its Precursors - Pancras Hogendoorn, Leiden University Medical Center, Leiden, Netherlands |
| 3:00 | Break |
| 3:30 | Osteogenic Neoplasia: The Good, the Bad and the Problematic - Kevin Raymond, M.D. Anderson Cancer Center, Houston, TX |
| 4:15 | The Spectrum of Osteofibrous Dysplasia to Adamantinoma - Edward McCarthy, Johns Hopkins Medical Center, Baltimore, MD |
| The entire membership is solicited for topics which are brought to the annual business meeting and voten on by membership. The final selection of topics is decided based on timeliness of the topic, the relevance to the practice of musculoskeletal pathology, and the novelty of the information. The purpose of this year's symposium is to present a combination of problematic areas of bone pathology along with areas featuring new ideas in our understanding of bone neoplasms. |
|
|
|
